SAINT-HERBLAIN, FRANCE: Valneva SE (Nasdaq: VALN) signed an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured for VLA2001 since reporting positive data for its Phase 3 clinical trial Cov-Compare. VLA2001 is…
Tag: Valneva SE
Valneva joins Euronext SBF 120 and CAC Mid 60 Indices
SAINT-HERBLAIN: Valneva SE has joined the SBF 120 and CAC Mid 60 indices, following the recent quarterly review of Euronext Paris Indices Committee, a news release said. The SBF 120 index is one of the flagship indices of the Paris Stock Exchange, consisting of the top 120 stocks listed on Euronext Paris in terms of…
UK orders another 40 million doses of Valneva COVID-19 vaccine for 2022
SAINT-HERBLAIN: Valneva SE reported the UK Government has exercised its option to order 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate for supply in 2022. This brings the total volume of the Valneva vaccine ordered by UK Government to 100 million doses and the UK Government retains options over a further 90 million…